Masters finalist Euprotec looking to double in size
EUPROTEC, the ambitious biotech company, has announced plans to raise external finance for the first time to help it double in size over the next two to three years.
The firm, which is based at Manchester Science Park and has grown from two to 17 staff since its launch in July 2008, is looking at a number of options to fund the next stage of development.
Chief executive Lloyd Payne said: “In a tough market place we have developed a strong growth story. We are profitable and have reinvested everything back into the business to fund growth and make sure we keep ahead of the game.
“We have strong aspirations for growth and we have recently finalised our strategy, and this is to double in size over the next couple of years. We will continue to focus on infection but there are there other areas which are aligned, which we feel can foster growth for us.
“From a funding perspective we have a number of options that we are bottoming out, ranging from public money to debt finance and equity investment. The market is tough, but I am looking forward to an exciting year.”
Dr Payne, who has taken part in the Goldman Sachs programme for small business growth, said Euprotech had succeeded in building its brand quickly and now counts some of the leading pharmaceutical companies on the world among its client list.
The company, which occupies 2,000sq ft of space at Williams House Manchester Science Park, is one of three contenders in TheBusinessDesk.com’s North West Business Masters awards in the innovator category .
The prestigious Business Masters awards take place on April 25 at the Lowry Hotel. Click here to book tickets for this not-to-be-missed event.
Euprotec provides contract research services to companies involved in the discovery and development of new drugs to treat infection, respiratory diseases and allergy.
It has customers in Europe, the US and South Africa and is part of a consortium which recently won a £1m contract from the US Department of Defense to develop an anti-infection treatment for soldiers.
